|
?:authorAffiliation
|
-
[\'Australian National University, Medical School, Canberra, Australia. frank.vanharen@anu.edu.au.\', \'Intensive Care Unit, the Canberra Hospital, Canberra, Australia. frank.vanharen@anu.edu.au.\', \'Sackler Institute of Pulmonary Pharmacology, King\'s College London, London, UK.\', \'Anaesthesia and Intensive Care Medicine, School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building, National University of Ireland Galway, Galway, Ireland.\', \'Department of Anaesthesia, University Hospital Galway, Saolta Hospital Group, Galway, Ireland.\', \'Critical Center, Corporació Sanitaria Parc Tauli , CIBER Enfermedades Respiratorias, Autonomous University of Barcelona, Sabadell, Spain.\', \'Institut d\'Investigació I Innovació Parc Tauli (I3PT), CIBER de Enfermedades Respiratorias, Sabadell, Spain.\', \'Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.\', \'Department of Critical Care Medicine, St Vincent\'s Hospital, Melbourne, Australia.\', \'School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK.\', \'Department of Respiratory Medicine, University of Southampton, Southampton, UK.\', \'National Infection Service, Public Health England, Porton Down, UK.\', \'Medicines Evaluation Unit, University of Manchester, Manchester, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}